Director/PDMR Shareholding

RNS Number : 4141F

GlaxoSmithKline PLC

20 February 2018

 

GlaxoSmithKline plc (the 'Company')

Shares sold to meet tax liabilities

Following the vesting of the pre-tax awards granted in 2015 under the GlaxoSmithKline Deferred Annual Bonus Plan ('DABP') on 15 February 2018 and as notified on 16 February 2018, the notifications that follow reflect change in the interests of the Person Discharging Managerial Responsibilities ('PDMRs') in American Depositary Shares ('ADS') of the Company arising from the sale of ADSs to meet tax liabilities.

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr D E Troy
b)	Position/status	SVP & General Counsel
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	GlaxoSmithKline plc American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	The sale of ADSs to meet tax liabilities further to the vesting of awards granted in 2015 under the Company's 2009 Deferred Annual Bonus Plan-Deferred Bonus and Matching Awards.
c)	Price(s) and volume(s)	Price(s) Volume(s) $37.4803 3,480 (Deferred) $37.4803 2,520 (Matching)
d)	Aggregated information Aggregated volume Price	6,000 $37.4803
e)	Date of the transaction	2018-02-16
f)	Place of the transaction	New York Stock Exchange (XNYS)

 

END

 

 

DSHXBLFLVLFFBBE